WASHINGTON - A commonly prescribed anti-diabetic drug can reduce an individual’s risk of developing pancreatic cancer by 62 percent, according to a new study.
The research from The University of Texas M. D. Anderson Cancer Center has been published in the Aug. 1 issue of Gastroenterology.
“This is the first epidemiological study of metformin in the cancer population, and it offers an exciting direction for future chemoprevention research for a disease greatly in need of both treatment and prevention strategies,” said Donghui Li, Ph.D., professor in M. D. Anderson’s Department of Gastrointestinal Medical Oncology.
“Metformin works by increasing the cellular sensitivity to insulin and decreasing its level circulating in diabetics. Insulin also seems to have a growth-promoting effect in cancer,” said Li, the study’s senior author.
“Metformin activates the AMP kinase, which is a cellular engery sensor. Recent publications have described that AMP kinase also plays an important role in the development of cancer by controlling cell division and growth,” the expert added.
Li also cited a previous animal study showing that metformin prevented pancreatic tumor development, as well as numerous epidemiologic studies in the diabetic population that showed taking the drug reduced the risk for cancer overall.
“Given these earlier findings, and knowing that diabetes is a risk factor for the development of pancreatic cancer and that 10 percent of such cancers are associated with diabetes, we wanted to better understand the specific association between different anti-diabetic therapies and this lethal disease,” explained Li.
For the case control study, the researchers enrolled 1,838 participants - 973 patients with pancreatic adenocarcinoma treated at M. D. Anderson between 2004 and 2008 to compare 863 cancer-free individuals, all companions of M. D. Anderson patients. (ANI)
Filed under Insulin, Metformin, News | Tags: Washington | Comment Below
Related?
Diabetes May Establish The Progression Of Pancreatic CancerMay 30th, 2006 Researchers of the Mayo Clinic looked at the CT scans of 23 pancreatic cancer patients taken before their diagnosis for unrelated reasons. Half of the patients had diabetes and saw the beginning of their diabetes over six months before they were diagnosed with cancer.
Diabetes Linked to Pancreatic Cancer RiskMarch 29th, 2006 High insulin levels and increased resistance to the hormone are found to be associated with a higher risk of pancreatic cancer. A healthy diet and lifestyle may help to reduce the risk of it.
LDL cholesterol level regulates type 2 diabetic cancer August 27th, 2008 The researchers from both the Universities of Hong Kong and China have found the link between the levels of LDL cholesterol and the risk of cancer in the patients of type 2 diabetes. Researchers have conducted the study of 6107 Chinese patients with type 2 diabetes and found a V-shaped risk relation between LDL cholesterol and cancer in patients not receiving statin therapy.
Popular diabetes drug can trigger pancreatic cancerMay 1st, 2009 WASHINGTON - A drug widely used in the treatment of Type-2 diabetes may trigger low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users. Pancreatitis simply means inflammation of the pancreas.
Men with Type 2 diabetes at risk of testosterone deficiencyMarch 16th, 2009 LONDON - More than 50 percent of men with Type-2 diabetes are at risk of developing testosterone deficiency syndrome (TDS), more than double the rate in the non-diabetic population. The symptoms are a drop in sex drive or libido, loss of energy, memory or concentration, negative moods, feelings of anxiety and feeling over-stressed.
Anti diabetic drug effcetive in prostate cancer among men November 21st, 2008 Finland researchers have found diabetes drugs can be used to control risk of prostate cancer. The study concluded that men who had a history of taking any diabetes medication had a 16 percent lower risk of prostate cancer.
Can your pancreas regenerateDecember 9th, 2008 The scenario of pancreatic regeneration in mammals has been well documented. It has been proven that pancreatic tissue able to regenerate in different species of mammal.
Moderate Drinking Reduces Diabetes and Kidney Cancer Risks in Older WomenJanuary 3rd, 2006 According to two recent studies older women who drink moderately might be reducing their risk of Type 2 diabetes as well as kidney cancer. Dr Michiel L Bots, researcher from the University Medical Center Utrecht in The Netherlands and study lead, and his team studied the alcohol consumption and risk of diabetes in over 16,300 women between the ages of 49 and 70 years.
